The pediatric and neonatal testing kit market size has grown strongly in recent years. It will grow from $4.18 billion in 2025 to $4.55 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to expansion of neonatal screening initiatives, rising awareness of congenital disorders, improvements in diagnostic assay technologies, growth of pediatric healthcare infrastructure, increased hospital-based testing adoption.
The pediatric and neonatal testing kit market size is expected to see strong growth in the next few years. It will grow to $6.59 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to expansion of precision pediatric diagnostics, rising investments in newborn health programs, growing adoption of molecular diagnostic technologies, increasing demand for rapid and portable testing kits, integration of digital health monitoring. Major trends in the forecast period include increasing adoption of point-of-care pediatric testing kits, rising use of dried blood spot screening, growing integration of genetic and metabolic testing, expansion of newborn screening programs, enhanced focus on early disease detection.
The growing neonatal and pediatric population is fueling the expansion of the pediatric and neonatal testing kit market. Neonates refer to newborns, typically from birth to 28 days old, while pediatric patients include children and infants aged 21 or younger at the time of diagnosis or treatment. The pediatric and neonatal testing kit market is essential for meeting the specific healthcare needs of this increasing population. For instance, in October 2025, according to the Australian Bureau of Statistics, an Australia-based government agency, a total of 292,318 births were registered in Australia in 2024, reflecting a 1.9% increase (an additional 5,320 births) compared to 2023, with 150,299 male and 142,019 female babies. Therefore, the rising neonatal and pediatric population is driving growth in the pediatric and neonatal testing kits market.
Major companies operating in the pediatric and neonatal testing market are focusing on developing advanced solutions, such as mass screening tests, to enhance early detection, reduce diagnostic delays, and improve treatment outcomes for newborns. Mass screening tests refer to diagnostic kits designed to identify serious conditions in newborns shortly after birth, enabling prompt medical intervention. For instance, in May 2024, Shimadzu Techno-Research, Inc., a Japan-based contract analysis company, launched a new contract service to conduct PCR testing for enhanced newborn mass screening. The service provides testing for severe rare diseases, including Severe Combined Immunodeficiency (SCID), B-cell Deficiency (BCD), and Spinal Muscular Atrophy (SMA), and is currently offered in 40 out of Japan’s 47 prefectures, with plans to expand nationwide through public funding. By partnering with hospitals and delivery facilities, the service aims to improve the health and welfare of newborns throughout Japan.
In March 2025, LaCAR MDx Technologies, a Belgium-based molecular diagnostics company, acquired the Newborn Screening Division of Baebies, Inc. for an undisclosed amount. Through this acquisition, LaCAR MDx aims to expand its pediatric and neonatal testing capabilities by integrating Baebies’ expertise in newborn screening and enhancing its portfolio of diagnostic tests for early detection of congenital disorders. Baebies, Inc. is a US-based company that provides pediatric and neonatal testing kits, including screening for metabolic, endocrine, and genetic conditions.
Major companies operating in the pediatric and neonatal testing kit market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic Plc, Siemens Healthineers, GE Healthcare GmbH, Eurofins Scientific SE, Trivitron Healthcare Pvt Ltd., Hologic Inc., PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Natus Medical Incorporated, BioFire Diagnostics LLC, Luminex Corporation, Meridian Bioscience Inc., MP Biomedicals LLC, ELITech Group SAS, Baebies Inc., Labsystems Diagnostics Oy, Beckman Coulter Inc., JETA Molecular BV, ZenTech SA, Hangzhou Testsea Biotechnology Co. Ltd.
North America was the largest region in the pediatric and neonatal testing kit market in 2025. The regions covered in the pediatric and neonatal testing kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric and neonatal testing kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pediatric and neonatal testing kit market by increasing costs of imported reagents, assay components, diagnostic instruments, sensors, and consumables. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported testing supplies, while Asia-Pacific faces pricing pressure on kit manufacturing and exports. These tariffs are raising testing costs and affecting procurement budgets. However, they are also supporting domestic production of diagnostic kits, regional reagent manufacturing, and increased investment in localized testing infrastructure.
The pediatric and neonatal testing kit market research report is one of a series of new reports that provides pediatric and neonatal testing kit market statistics, including pediatric and neonatal testing kit industry global market size, regional shares, competitors with a pediatric and neonatal testing kit market share, detailed pediatric and neonatal testing kit market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric and neonatal testing kit industry. This pediatric and neonatal testing kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A pediatric and neonatal testing kit encompasses a compilation of specialized medical devices, instruments, and tools meticulously crafted for the evaluation and diagnosis of infants, newborns, and children. These kits serve as indispensable resources for healthcare professionals, including pediatricians, neonatologists, nurses, and other medical personnel, facilitating the precise diagnosis, monitoring, and treatment of pediatric patients.
Key test types featured in pediatric and neonatal testing kits include dried blood spot, hearing screening, critical congenital heart defect (CCHD), among others. The dried blood spot (DBS) test, a diagnostic technique, entails the collection of a small blood volume from individuals, allowing it to dry on a specialized filter paper. The product offerings include assay kits, reagents, and instruments employing various cutting-edge technologies such as tandem mass spectrometry, pulse oximetry, enzyme-based assays, DNA-based assays, electrophoresis, and more. These advanced testing solutions cater to a diverse range of end users, including hospitals, diagnostic centers, maternity facilities, specialty clinics, and other healthcare institutions.
The pediatric and neonatal testing kit market consists of sales of maternal blood screening, ultrasound tests, amniocentesis, and glucose screening. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The pediatric and neonatal testing kit market size is expected to see strong growth in the next few years. It will grow to $6.59 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to expansion of precision pediatric diagnostics, rising investments in newborn health programs, growing adoption of molecular diagnostic technologies, increasing demand for rapid and portable testing kits, integration of digital health monitoring. Major trends in the forecast period include increasing adoption of point-of-care pediatric testing kits, rising use of dried blood spot screening, growing integration of genetic and metabolic testing, expansion of newborn screening programs, enhanced focus on early disease detection.
The growing neonatal and pediatric population is fueling the expansion of the pediatric and neonatal testing kit market. Neonates refer to newborns, typically from birth to 28 days old, while pediatric patients include children and infants aged 21 or younger at the time of diagnosis or treatment. The pediatric and neonatal testing kit market is essential for meeting the specific healthcare needs of this increasing population. For instance, in October 2025, according to the Australian Bureau of Statistics, an Australia-based government agency, a total of 292,318 births were registered in Australia in 2024, reflecting a 1.9% increase (an additional 5,320 births) compared to 2023, with 150,299 male and 142,019 female babies. Therefore, the rising neonatal and pediatric population is driving growth in the pediatric and neonatal testing kits market.
Major companies operating in the pediatric and neonatal testing market are focusing on developing advanced solutions, such as mass screening tests, to enhance early detection, reduce diagnostic delays, and improve treatment outcomes for newborns. Mass screening tests refer to diagnostic kits designed to identify serious conditions in newborns shortly after birth, enabling prompt medical intervention. For instance, in May 2024, Shimadzu Techno-Research, Inc., a Japan-based contract analysis company, launched a new contract service to conduct PCR testing for enhanced newborn mass screening. The service provides testing for severe rare diseases, including Severe Combined Immunodeficiency (SCID), B-cell Deficiency (BCD), and Spinal Muscular Atrophy (SMA), and is currently offered in 40 out of Japan’s 47 prefectures, with plans to expand nationwide through public funding. By partnering with hospitals and delivery facilities, the service aims to improve the health and welfare of newborns throughout Japan.
In March 2025, LaCAR MDx Technologies, a Belgium-based molecular diagnostics company, acquired the Newborn Screening Division of Baebies, Inc. for an undisclosed amount. Through this acquisition, LaCAR MDx aims to expand its pediatric and neonatal testing capabilities by integrating Baebies’ expertise in newborn screening and enhancing its portfolio of diagnostic tests for early detection of congenital disorders. Baebies, Inc. is a US-based company that provides pediatric and neonatal testing kits, including screening for metabolic, endocrine, and genetic conditions.
Major companies operating in the pediatric and neonatal testing kit market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic Plc, Siemens Healthineers, GE Healthcare GmbH, Eurofins Scientific SE, Trivitron Healthcare Pvt Ltd., Hologic Inc., PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Natus Medical Incorporated, BioFire Diagnostics LLC, Luminex Corporation, Meridian Bioscience Inc., MP Biomedicals LLC, ELITech Group SAS, Baebies Inc., Labsystems Diagnostics Oy, Beckman Coulter Inc., JETA Molecular BV, ZenTech SA, Hangzhou Testsea Biotechnology Co. Ltd.
North America was the largest region in the pediatric and neonatal testing kit market in 2025. The regions covered in the pediatric and neonatal testing kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric and neonatal testing kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the pediatric and neonatal testing kit market by increasing costs of imported reagents, assay components, diagnostic instruments, sensors, and consumables. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported testing supplies, while Asia-Pacific faces pricing pressure on kit manufacturing and exports. These tariffs are raising testing costs and affecting procurement budgets. However, they are also supporting domestic production of diagnostic kits, regional reagent manufacturing, and increased investment in localized testing infrastructure.
The pediatric and neonatal testing kit market research report is one of a series of new reports that provides pediatric and neonatal testing kit market statistics, including pediatric and neonatal testing kit industry global market size, regional shares, competitors with a pediatric and neonatal testing kit market share, detailed pediatric and neonatal testing kit market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric and neonatal testing kit industry. This pediatric and neonatal testing kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A pediatric and neonatal testing kit encompasses a compilation of specialized medical devices, instruments, and tools meticulously crafted for the evaluation and diagnosis of infants, newborns, and children. These kits serve as indispensable resources for healthcare professionals, including pediatricians, neonatologists, nurses, and other medical personnel, facilitating the precise diagnosis, monitoring, and treatment of pediatric patients.
Key test types featured in pediatric and neonatal testing kits include dried blood spot, hearing screening, critical congenital heart defect (CCHD), among others. The dried blood spot (DBS) test, a diagnostic technique, entails the collection of a small blood volume from individuals, allowing it to dry on a specialized filter paper. The product offerings include assay kits, reagents, and instruments employing various cutting-edge technologies such as tandem mass spectrometry, pulse oximetry, enzyme-based assays, DNA-based assays, electrophoresis, and more. These advanced testing solutions cater to a diverse range of end users, including hospitals, diagnostic centers, maternity facilities, specialty clinics, and other healthcare institutions.
The pediatric and neonatal testing kit market consists of sales of maternal blood screening, ultrasound tests, amniocentesis, and glucose screening. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Pediatric and Neonatal Testing Kit Market Characteristics
3. Pediatric and Neonatal Testing Kit Market Supply Chain Analysis
4. Global Pediatric and Neonatal Testing Kit Market Trends and Strategies
5. Pediatric and Neonatal Testing Kit Market Analysis of End Use Industries
7. Global Pediatric and Neonatal Testing Kit Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Pediatric and Neonatal Testing Kit Total Addressable Market (TAM) Analysis for the Market
9. Pediatric and Neonatal Testing Kit Market Segmentation
10. Pediatric and Neonatal Testing Kit Market Regional and Country Analysis
11. Asia-Pacific Pediatric and Neonatal Testing Kit Market
12. China Pediatric and Neonatal Testing Kit Market
13. India Pediatric and Neonatal Testing Kit Market
14. Japan Pediatric and Neonatal Testing Kit Market
15. Australia Pediatric and Neonatal Testing Kit Market
16. Indonesia Pediatric and Neonatal Testing Kit Market
17. South Korea Pediatric and Neonatal Testing Kit Market
18. Taiwan Pediatric and Neonatal Testing Kit Market
19. South East Asia Pediatric and Neonatal Testing Kit Market
20. Western Europe Pediatric and Neonatal Testing Kit Market
21. UK Pediatric and Neonatal Testing Kit Market
22. Germany Pediatric and Neonatal Testing Kit Market
23. France Pediatric and Neonatal Testing Kit Market
24. Italy Pediatric and Neonatal Testing Kit Market
25. Spain Pediatric and Neonatal Testing Kit Market
26. Eastern Europe Pediatric and Neonatal Testing Kit Market
27. Russia Pediatric and Neonatal Testing Kit Market
28. North America Pediatric and Neonatal Testing Kit Market
29. USA Pediatric and Neonatal Testing Kit Market
30. Canada Pediatric and Neonatal Testing Kit Market
31. South America Pediatric and Neonatal Testing Kit Market
32. Brazil Pediatric and Neonatal Testing Kit Market
33. Middle East Pediatric and Neonatal Testing Kit Market
34. Africa Pediatric and Neonatal Testing Kit Market
36. Pediatric and Neonatal Testing Kit Market Competitive Landscape and Company Profiles
37. Pediatric and Neonatal Testing Kit Market Other Major and Innovative Companies
40. Pediatric and Neonatal Testing Kit Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Pediatric And Neonatal Testing Kit Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses pediatric and neonatal testing kit market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pediatric and neonatal testing kit? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric and neonatal testing kit market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Test Type: Dried Blood Spot; Hearing Screening; Critical Congenital Heart Defect (CCHD); Other Test Types2) By Product: Assay Kits And Reagents; Instruments
3) By Technology: Tandem Mass Spectrometry; Pulse Oximetry; Enzyme-Based Assays; DNA Based Assays; Electrophoresis; Others Technologies
4) By End User: Hospitals; Diagnostic Centers; Maternity And Specialty Clinics; Other End Users
Subsegments:
1) By Dried Blood Spot: Newborn Screening Panels; Genetic Testing; Infectious Disease Screening2) By Hearing Screening: Automated Auditory Brainstem Response (ABR) Tests; Otoacoustic Emissions (OAE) Tests; Portable Hearing Screening Devices
3) By Critical Congenital Heart Defect (CCHD): Pulse Oximetry Screening Kits; Echocardiography Screening Tools; Clinical Assessment Protocols
4) By Other Test Types: Blood Gas Analysis Kits; Urine Testing Kits; Infectious Disease Testing; Point-of-Care Testing Devices
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Medtronic Plc; Siemens Healthineers; GE Healthcare GmbH; Eurofins Scientific SE; Trivitron Healthcare Pvt Ltd.; Hologic Inc.; PerkinElmer Inc.; Quidel Corporation; Bio-Rad Laboratories Inc.; QIAGEN NV; Natus Medical Incorporated; BioFire Diagnostics LLC; Luminex Corporation; Meridian Bioscience Inc.; MP Biomedicals LLC; ELITech Group SAS; Baebies Inc.; Labsystems Diagnostics Oy; Beckman Coulter Inc.; JETA Molecular BV; ZenTech SA; Hangzhou Testsea Biotechnology Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Pediatric and Neonatal Testing Kit market report include:- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Medtronic Plc
- Siemens Healthineers
- GE Healthcare GmbH
- Eurofins Scientific SE
- Trivitron Healthcare Pvt Ltd.
- Hologic Inc.
- PerkinElmer Inc.
- Quidel Corporation
- Bio-Rad Laboratories Inc.
- QIAGEN NV
- Natus Medical Incorporated
- BioFire Diagnostics LLC
- Luminex Corporation
- Meridian Bioscience Inc.
- MP Biomedicals LLC
- ELITech Group SAS
- Baebies Inc.
- Labsystems Diagnostics Oy
- Beckman Coulter Inc.
- JETA Molecular BV
- ZenTech SA
- Hangzhou Testsea Biotechnology Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.55 Billion |
| Forecasted Market Value ( USD | $ 6.59 Billion |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
